Bright Minds Biosciences Inc. Common Stock DRUG
$26.20
-52.35%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 6-K | Foreign issuer report | 2026-11-02 | View → |
| 6-K | FORM 6-K | 2026-10-02 | View → |
| 6-K | FORM 6-K | 2026-10-01 | View → |
| 6-K | FORM 6-K | 2026-08-17 | View → |
| 6-K | FORM 6-K | 2026-06-03 | View → |
| 6-K | FORM 6-K | 2026-06-02 | View → |
| 6-K | Foreign issuer report | 2026-05-28 | View → |
| 6-K | FORM 6-K | 2026-05-20 | View → |
| 4 | Insider transaction | 2026-04-30 | View → |
| 6-K | FORM 6-K | 2026-02-13 | View → |
| 6-K | FORM 6-K | 2026-01-09 | View → |
| 6-K | FORM 6-K | 2026-01-09 | View → |
| 424B5 | FORM 424B5 | 2026-01-09 | View → |
| 6-K | Foreign issuer report | 2026-01-08 | View → |
| 6-K | FORM 6-K | 2026-01-07 | View → |
| 424B5 | FORM 424B5 | 2026-01-07 | View → |
| 6-K | Foreign issuer report | 2026-01-07 | View → |
| 6-K | Foreign issuer report | 2026-01-06 | View → |
| 6-K | Foreign issuer report | 2026-01-05 | View → |
| 6-K | FORM 6-K | 2025-11-17 | View → |
| 6-K | FORM 6-K | 2025-11-07 | View → |
| 6-K | FORM 6-K | 2025-11-07 | View → |
| 6-K | Foreign issuer report | 2025-09-05 | View → |
| 6-K | FORM 6-K | 2025-08-15 | View → |
| 6-K | FORM 6-K | 2025-08-11 | View → |
| 6-K | Foreign issuer report | 2025-05-28 | View → |
| 6-K | Foreign issuer report | 2025-05-21 | View → |
| 6-K | Foreign issuer report | 2025-05-14 | View → |
| 6-K | Foreign issuer report | 2025-04-29 | View → |
| 6-K | Foreign issuer report | 2025-03-05 | View → |
| 6-K | Foreign issuer report | 2025-02-24 | View → |
| 6-K | FORM 6-K | 2025-02-14 | View → |
| 6-K | Foreign issuer report | 2025-01-08 | View → |
| 20-F | FORM 20-F | 2024-12-31 | View → |
| 6-K | FORM 6-K | 2024-11-21 | View → |
| SC 13G | SC 13G | 2024-11-12 | View → |
| 4 | Insider transaction | 2024-11-06 | View → |
| 6-K | FORM 6-K | 2024-11-05 | View → |
| SC 13G | Passive stake disclosure | 2024-10-25 | View → |
| SC 13G | Passive stake disclosure | 2024-10-23 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $26.20
- Market Cap
- $542.33 million
- 52-Week Range
- $18.90 – $123.75
- Average Volume
- 192K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.